全球權威調研機構Technavio最新報告顯示，預計在2013到2018年全球基因組學和蛋白組學分析儀器市場將保持7.83%的復合年增長率。
基因組學研究的是基因及其功能，蛋白質組學研究的是蛋白質組或組蛋白的結構和功能，兩者均使用分子生物學和生物信息學的工具和技術。基因組學通過繪制基因和DNA序列來了解基因組的結構和功能。一個蛋白質組是一個基因組在特定時間內表達的一整套蛋白質。蛋白質組學主要涉及的是使用分子生物學、生物化學和遺傳學來分析蛋白質，這些蛋白質是通過基因編碼而來。蛋白質是所有細胞的主要組分，而且控制細胞的不同功能特性。基因組和蛋白質組結構或功能的缺陷可能導致疾病，因此基因組學和蛋白組學技術在科研、新藥研發、疾病診斷中發揮著重要作用。這些應用都需要基因和蛋白缺陷的識別和研究，而基因組和蛋白質組的蛋白質分離、凈化、識別、量化和分析都需要儀器、試劑和軟件。基因組學和蛋白質組學用到多種分析儀器，但應用最廣泛的是色譜系統、質譜系統、PCR系統和下一代測序系統。
這個市場發展的主要推動力為基因組學和蛋白組學技術的完善，主要挑戰在于基因組學和蛋白組學知識的缺乏，主要趨勢為聚焦于藥物研發和疾病診斷。
The global market for genomics and proteomics analysis instruments is expected to grow at a compound annual rate of 7.83 percent between 2013 and 2018, according to a new report by Technavio, a leading global research firm.
Genomics is the study of genes and their functions, proteomics is the study of protein structure and function of the protein group or group, both the use of tools and techniques of molecular biology and bioinformatics. Genomics works by mapping genes and DNA sequences to understand the structure and function of the genome. A proteome is a set of proteins expressed by a genome at a specific time. Proteomics involves the use of molecular biology, biochemistry and genetics to analyze proteins encoded by genes. Protein is the main component of all cells and controls the different functional properties of cells. Defects in the structure or function of genomes and proteomics may lead to diseases, so genomics and proteomics technologies play an important role in scientific research, new drug development and disease diagnosis. These applications require the identification and study of gene and protein defects, and the separation, purification, identification, quantification and analysis of the genome and proteome proteins require instruments, reagents and software. Genomics and proteomics are used in a variety of analytical instruments, but the most widely used are chromatographic systems, mass spectrometry systems, PCR systems and next-generation sequencing systems.
The main driving factor for the growth of the market for the perfection of the technology of genomics and proteomics, the main challenge is the lack of knowledge of genomics and proteomics, the main trend to focus on drug research and disease diagnosis.
